ReviewAlzheimer's research & therapy2022

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer's disease.

Byron Creese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.